Loading...

Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma

Bone marrow plasmacytoid dendritic cells (pDCs) in patients with multiple myeloma (MM) promote tumor growth, survival, drug resistance, and immune suppression. Understanding the molecular signaling crosstalk among the tumor cells, pDCs and immune cells will identify novel therapeutic approaches to e...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncogene
Main Authors: Ray, Arghya, Song, Yan, Du, Ting, Chauhan, Dharminder, Anderson, Kenneth C.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7132141/
https://ncbi.nlm.nih.gov/pubmed/32024967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1172-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!